*Surgical Treatment of Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.99776*

encephaloduroarteriosynangiosis and bifrontal encephalogaleo (periosteal) synangiosis in pediatric moyamoya disease. *Neurosurgery* **62**, 1456- 1464 (2008).

[151] Kalra, N., Bautista, M., McCullagh, H. & Tyagi, A. PedsQL Score Post Encephalo-duro-arterio-myosynangiosis Procedure for Moyamoya Disease: A Single Center Experience. *World Neurosurg.* **144**, e674– e678 (2020).

[152] Ogiwara, H. & Morota, N. Bifrontal encephalogaleosynangiosis for children with moyamoya disease. *J. Neurosurg. Pediatr.* **10**, 246-251 (2012).

[153] Kim, C.-Y. *et al.*

Encephaloduroarteriosynangiosis with bifrontal encephalogaleo(periosteal) synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes. *Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.* **19**, 316- 324 (2003).

[154] Zhao, Y. *et al.* Modified encephaloduro-periosteal-synangiosis (EDPS) for the revascularization of anterior cerebral artery territory in moyamoya disease: A single-center experience. *Clin. Neurol. Neurosurg.* **178**, 86-92 (2019).

[155] Li, W. *et al.* Complications of contralateral C-7 transfer through the modified prespinal route for repairing brachial plexus root avulsion injury: a retrospective study of 425 patients. *J. Neurosurg.* **122**, 1421-1428 (2015).

[156] Karasawa, J., Kikuchi, H., Kawamura, J. & Sakai, T. Intracranial transplantation of the omentum for cerebrovascular moyamoya disease: a two-year follow-up study. *Surg. Neurol.* **14**, 444-449 (1980).

[157] Navarro, R. *et al.* Less invasive pedicled omental-cranial transposition in pediatric patients with moyamoya

disease and failed prior revascularization. *Neurosurgery* **10 Suppl 1**, 1-14 (2014).

[158] Mirone, G. *et al.* Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results. *World Neurosurg.* **127**, e843– e855 (2019).

[159] Zhao, X., Wang, C., Ji, Y., Han, C. & Wang, M. Therapeutic effect of multiple burr hole operation combined with dural inversion and periosteal synangiosis for moyamoya disease. *Br. J. Neurosurg.* **29**, 811-817 (2015).

[160] McLaughlin, N. & Martin, N. A. Effectiveness of burr holes for indirect revascularization in patients with moyamoya disease-a review of the literature. *World Neurosurg.* **81**, 91-98 (2014).

[161] Kawaguchi, T. *et al.* Multiple burr-hole operation for adult moyamoya disease. *J. Neurosurg.* **84**, 468- 476 (1996).

[162] Oliveira, R. S. de *et al.* Effect of multiple cranial burr hole surgery on prevention of recurrent ischemic attacks in children with moyamoya disease. *Neuropediatrics* **40**, 260-264 (2009).

[163] Kazumata, K. *et al.* The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. *J. Neurosurg.* **121**, 432-440 (2014).

[164] Wouters, A., Smets, I., Van den Noortgate, W., Steinberg, G. K. & Lemmens, R. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis. *Acta Neurol. Belg.* **119**, 305-313 (2019).

[165] Houkin, K., Nakayama, N., Kuroda, S., Ishikawa, T. & Nonaka, T. How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. *Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.* **20**, 734-741 (2004).

[166] Pandey, P. & Steinberg, G. K. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. *J. Neurosurg.* **115**, 328-336 (2011).

[167] Cahan, L. D. Failure of encephaloduro-arterio-synangiosis procedure in moyamoya disease. *Pediatr. Neurosci.* **12**, 58-62 (1985).

[168] Miyamoto, S. *et al.* Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases. *J. Neurosurg.* **68**, 537-543 (1988).

[169] Lanterna, L. A. Moyamoya Disease: From Hypoperfusion to Network Disruption. *World Neurosurg.* **104**, 1036-1037 (2017).

[170] Krayenbühl, H. A. The Moyamoya syndrome and the neurosurgeon. *Surg. Neurol.* **4**, 353-360 (1975).

[171] Kikuchi, H & Karasawa, J. STAcortical MCA anastomosis for cerebrovascular occlusive disease. *No Shinkei Geka.* **1**, 15-19 (1973).

[172] Nakagawa, Y. *et al.* [Reconstructive operation for moyamoya disease. Surgical indication for the hemorrhagic type, and preferable operative methods]. *Neurol. Med. Chir. (Tokyo)* **23**, 464-470 (1983).

[173] Spetzler, R. F., Roski, R. A. & Kopaniky, D. R. Alternative superficial temporal artery to middle cerebral artery revascularization procedure. *Neurosurgery* **7**, 484-487 (1980).

[174] Takeuchi, S. *et al.* Treatment of moyamoya disease by temporal muscle graft 'encephalo-myo-synangiosis'. *Childs Brain* **10**, 1-15 (1983).

[175] Matsushima, Y *et al.* A new operative method for 'moyamoya' disease: A presentation of a case who underwent encephalo-duroarterio(STA)-synangiosis. *Shoni No Noshinkei* **5**, 249-255 (1980).

[176] Matsushima, Y. & Inaba, Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. *Childs Brain* **11**, 155-170 (1984).

[177] Tenjin, H. & Ueda, S. Multiple EDAS (encephalo-duro-arteriosynangiosis). Additional EDAS using the frontal branch of the superficial temporal artery (STA) and the occipital artery for pediatric moyamoya patients in whom EDAS using the parietal branch of STA was insufficient. *Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.* **13**, 220-224 (1997).

[178] Ge, P. *et al.* Encephaloduroarterio synangiosis versus conservative treatment for patients with moyamoya disease at late Suzuki stage. *J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas.* **50**, 277-280 (2018).

[179] Wang, Q.-N. *et al.* Encephaloduro arteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center. *J. Neurosurg.* **130**, 1898-1905 (2019).

[180] Ren, B. *et al.* Surgical outcomes following encephaloduroarterio synangiosis in adult moyamoya disease associated with Type 2 diabetes. *J. Neurosurg.* **125**, 308-314 (2016).

[181] Chiarelli, P. A., Patel, A. P., Lee, A., Chandra, S. R. & Sekhar, L. N. Sternocleidomastoid Encephalomyo synangiosis for Treatment-Resistant

*Surgical Treatment of Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.99776*

Moyamoya Disease. *Oper. Neurosurg. Hagerstown Md* **17**, E23–E28 (2019).

[182] Yoshioka, N., Tominaga, S. & Inui, T. Cerebral revascularization using omentum and serratus anterior muscle free flap transfer for adult moyamoya disease: case report. *Surg. Neurol.* **46**, 430-435; discussion 435-436 (1996).

[183] Touho, H., Karasawa, J. & Ohnishi, H. Cerebral revascularization using gracilis muscle transplantation for childhood moyamoya disease. *Surg. Neurol.* **43**, 191-197; discussion 197- 198 (1995).

[184] Yoshioka, N. & Tominaga, S. Cerebral revascularization using latissimus dorsi muscle free flap transfer--technical note. *Neurol. Med. Chir. (Tokyo)* **37**, 288-291 (1997).

[185] Endo, M., Kawano, N., Miyaska, Y. & Yada, K. Cranial burr hole for revascularization in moyamoya disease. *J. Neurosurg.* **71**, 180-185 (1989).

[186] Inoue, T *et al.* Frontal encephalomyo-arterio-synangiosis (EMAS). *Nosotchu No Geka* **20**, 297-300.

[187] Kinugasa, K. *et al.* Ribbon enchephalo-duro-arterio-myosynangiosis for moyamoya disease. *Surg. Neurol.* **41**, 455-461 (1994).

[188] Thines, L. *et al.* Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience. *Rev. Neurol. (Paris)* **171**, 31-44 (2015).

[189] Abla, A. A. *et al.* Surgical outcomes for moyamoya angiopathy at barrow neurological institute with comparison of adult indirect encephaloduroarteriosynangiosis bypass, adult direct superficial temporal artery-to-middle cerebral artery bypass, and pediatric bypass: 154 revas cularization surgeries in 140 affected

hemispheres. *Neurosurgery* **73**, 430- 439 (2013).

[190] Zhao, M. *et al.* Adolescents with moyamoya disease: clinical features, surgical treatment and long-term outcomes. *Acta Neurochir. (Wien)* **159**, 2071-2080 (2017).

[191] King, J. A. J., Armstrong, D., Vachhrajani, S. & Dirks, P. B. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography. *J. Neurosurg. Pediatr.* **5**, 184-189 (2010).

[192] Wang, G. *et al.* Membrane Retraction Technique in Bypass Surgery for the Treatment of Adult Moyamoya Disease with Deep-Seated Recipient Artery. *World Neurosurg.* **139**, 294- 297 (2020).

[193] Ge, P. *et al.* Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease. *BMC Neurol.* **20**, 28 (2020).

[194] Kim, S.-K. *et al.* Pediatric moyamoya disease: An analysis of 410 consecutive cases. *Ann. Neurol.* **68**, 92-101 (2010).

[195] Mizoi, K., Kayama, T., Yoshimoto, T. & Nagamine, Y. Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? *Surg. Neurol.* **45**, 541-548; discussion 548-549 (1996).

[196] Kim, T., Oh, C. W., Bang, J. S., Kim, J. E. & Cho, W.-S. Moyamoya Disease: Treatment and Outcomes. *J. Stroke* **18**, 21-30 (2016).

[197] Liu, J. J. & Steinberg, G. K. Direct Versus Indirect Bypass for Moyamoya Disease. *Neurosurg. Clin. N. Am.* **28**, 361-374 (2017).

[198] Feghali, J. *et al.* Differing Surgical Outcomes in a Multiethnic Cohort

Suggest Racial Phenotypes in Moyamoya Disease. *World Neurosurg.* **128**, e865–e872 (2019).

[199] Isono, M. *et al.* Long-term outcomes of pediatric moyamoya disease treated by encephalo-duroarterio-synangiosis. *Pediatr. Neurosurg.* **36**, 14-21 (2002).

[200] Chen, C., Wang, H., Hou, B., Luo, L. & Guo, Y. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis. *World Neurosurg.* **110**, e203–e211 (2018).

[201] Touho, H., Karasawa, J., Ohnishi, H., Yamada, K. & Shibamoto, K. Surgical reconstruction of failed indirect anastomosis in childhood Moyamoya disease. *Neurosurgery* **32**, 935-940; discussion 940 (1993).

[202] Piao, J., Wu, W., Yang, Z. & Yu, J. Research Progress of Moyamoya Disease in Children. *Int. J. Med. Sci.* **12**, 566- 575 (2015).

[203] Xu, B. *et al.* Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myosynangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results. *Chin. Med. J. (Engl.)* **125**, 4398-4405 (2012).

[204] Noshiro, S. *et al.* Neuromodulatory Role of Revascularization Surgery in Moyamoya Disease. *World Neurosurg.* **91**, 473-482 (2016).

[205] Deng, X. *et al.* Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study. *J. Neurosurg.* **128**, 1327-1337 (2018).

[206] Ishikawa, T., Houkin, K., Kamiyama, H. & Abe, H. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. *Stroke* **28**, 1170-1173 (1997).

[207] Kim, D.-S. *et al.* Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. *Neurol. Med. Chir. (Tokyo)* **52**, 333-338 (2012).

[208] Czabanka, M., Vajkoczy, P., Schmiedek, P. & Horn, P. Agedependent revascularization patterns in the treatment of moyamoya disease in a European patient population. *Neurosurg. Focus* **26**, E9 (2009).

[209] Jagdevan, S., Sriganesh, K., Pandey, P., Reddy, M. & Umamaheswara Rao, G. S. Anesthetic factors and outcome in children undergoing indirect revascularization procedure for moyamoya disease: An Indian perspective. *Neurol. India* **63**, 702-706 (2015).

[210] Iwama, T., Hashimoto, N. & Yonekawa, Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. *Neurosurgery* **38**, 1120-1125; discussion 1125-1126 (1996).

[211] Arias, E. J., Derdeyn, C. P., Dacey, R. G. & Zipfel, G. J. Advances and surgical considerations in the treatment of moyamoya disease. *Neurosurgery* **74 Suppl 1**, S116-125 (2014).

[212] Lee, J. K., Williams, M., Reyes, M. & Ahn, E. S. Cerebrovascular blood pressure autoregulation monitoring and postoperative transient ischemic attack in pediatric moyamoya vasculopathy. *Paediatr. Anaesth.* **28**, 94-102 (2018).

[213] Nomura, S. *et al.* Perioperative management protocols for children with moyamoya disease. *Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.* **17**, 270-274 (2001).

[214] Schubert, G. A. *et al.* Perfusion characteristics of Moyamoya disease: an anatomically and clinically oriented analysis and comparison. *Stroke* **45**, 101-106 (2014).

*Surgical Treatment of Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.99776*

[215] Jo, K.-I., Yeon, J. Y., Hong, S.-C. & Kim, J.-S. Clinical course of asymptomatic adult moyamoya disease. *Cerebrovasc. Dis. Basel Switz.* **37**, 94-101 (2014).

[216] Cheung, A. H.-K. *et al.* Surgical Outcome for Moyamoya Disease: Clinical and Perfusion Computed Tomography Correlation. *World Neurosurg.* **98**, 81-88 (2017).

[217] Matsushima, T. *et al.* Reoperation for moyamoya disease refractory to encephalo-duro-arterio-synangiosis. *Acta Neurochir. (Wien)* **107**, 129- 132 (1990).

[218] Kim, T. *et al.* Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. *J. Neurosurg.* **124**, 1788-1793 (2016).

[219] Qian, C. *et al.* The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease: A Meta-Analysis. *Medicine (Baltimore)* **94**, e2218 (2015).

[220] Wang, G., Zhang, X., Feng, M., Liu, X. & Guo, F. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease. *J. Craniofac. Surg.* **28**, 2113-2116 (2017).

[221] Jang, D.-K. *et al.* Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. *J. Neurosurg.* **127**, 492-502 (2017).

[222] Fujii, K., Ikezaki, K., Irikura, K., Miyasaka, Y. & Fukui, M. The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. *Clin. Neurol. Neurosurg.* **99 Suppl 2**, S194- 195 (1997).

[223] Funaki, T. *et al.* Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease: a descriptive longitudinal study at a single center. *Acta Neurochir. (Wien)* **156**, 551-559; discussion 559 (2014).

[224] Cho, W.-S. *et al.* Long-term outcomes after combined revascularization surgery in adult moyamoya disease. *Stroke* **45**, 3025- 3031 (2014).

[225] Liu, X. *et al.* Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. *J. Neurosurg.* **122**, 392-399 (2015).

[226] Starke, R. M., Komotar, R. J. & Connolly, E. S. Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. *Neurosurg. Focus* **26**, E8 (2009).

[227] Funaki, T., Takahashi, J. C. & Miyamoto, S. Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease. *Neurol. Med. Chir. (Tokyo)* **58**, 240-246 (2018).

[228] Yamao, Y. *et al.* Revascularization Surgery in Childhood Associated with a Low Incidence of Microbleeds in Adult Patients with Moyamoya. *World Neurosurg.* **133**, e716–e721 (2020).

[229] Fiaschi, P. *et al.* Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome. *Neurosurg. Rev.* (4):1877-1887 (2020) doi:10.1007/s10143-020-01393-1.

[230] Macyszyn, L. *et al.* Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. *J. Neurosurg.* **126**, 1523-1529 (2017).

[231] Zhai, X. *et al.* Risk Factors Associated with Neurologic Deterioration After Combined Direct and Indirect Revascularization in Patients with Moyamoya Disease on the East Coast of China. *World Neurosurg.* **118**, e92–e98 (2018).

[232] Hyun, S.-J., Kim, J.-S. & Hong, S.-C. Prognostic factors associated with perioperative ischemic complications in adult-onset moyamoya disease. *Acta Neurochir. (Wien)* **152**, 1181- 1188 (2010).

[233] Kim, S.-H., Choi, J.-U., Yang, K.-H., Kim, T.-G. & Kim, D.-S. Risk factors for postoperative ischemic complications in patients with moyamoya disease. *J. Neurosurg.* **103**, 433-438 (2005).

[234] Lee, J. Y. *et al.* Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. *Cerebrovasc. Dis. Basel Switz.* **31**, 230-237 (2011).

[235] Zeng, H. *et al.* Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series. *World Neurosurg.* **146**, e955–e960 (2021).
